Publique en esta revista
Información de la revista
Vol. 25. Núm. 8.
Páginas 336-344 (Noviembre - Diciembre 1989)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 25. Núm. 8.
Páginas 336-344 (Noviembre - Diciembre 1989)
DOI: 10.1016/S0300-2896(15)31681-1
Acceso a texto completo
Fibrosis pulmonar: perspectivas actuales
Visitas
...
M. Jordana, A. Xaubet, J. Gauldie
Department of Pathology. Molecular Virology and Immunology Program. McMaster University. Hamilton, Ontario, Canadá
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
I.Y. Adamson, D.H. Bowden.
Endothelial injury and repair radiation-induced pulmonary fibrosis.
Am J Pathol, 112 (1983), pp. 224-230
[2.]
G.L. Snider, J.A. Hayes, et al.
Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomyc pathology serology.
Am Rev Respir Dis, 117 (1978), pp. 1.099-1.108
[3.]
P. Smith, D. Heath, et al.
The pathogenesis and structure of paraquat-induced pulmonary fibrosis in rats.
J Pathol, 114 (1974), pp. 57-67
[4.]
A.L. Katzenstein.
Pathogenesis of “fibrosis” in interstitial pneumonia: An electronmicroscopy study.
Hum Pathol, 16 (1985), pp. 1.015-1.024
[5.]
G. Raghu, L. Striker, et al.
Extracellular matrix in normal and fibrotic human lungs.
Am Rev Respir Dis, 131 (1985), pp. 182-189
[6.]
B.C. Starcher, C. Kuhn, et al.
Increased elastin and collagen content of the lungs of hamsters receiving an intratracheal injection of bleomycin.
Am Rev Respir Dis, 117 (1978), pp. 299-305
[7.]
J.B. Kavlinsky.
Glycosaminoglicans in emphysematous and fibrotic hamster lungs.
Am Rev Respir dis, 125 (1982), pp. 85-86
[8.]
R.S. Thrall, R.W. Barton, et al.
Differential cellular analysis of bronchoalveolar lavage fluid obtained at various stages during the development of bleomycin-induced pulmonary fibrosis in the rat.
Am Rev Respir Dis, 126 (1982), pp. 488-492
[9.]
E. Fassle.
Pathogenesis of pulmonary fibrosis induced by chrysotile asbestos Longitudinal light and electron microscopic studies on the rat model.
Virchows Archiv A, 408 (1986), pp. 329-346
[10.]
W.M. Haschek, A.J.P. Kelin-Szanto, et al.
Long-term morphologic and biochemical features of experimentally-induced lung fibrosis in the mouse.
Lab Invest, 46 (1982), pp. 438-449
[11.]
Y. Fukuda, V.J. Ferrans, et al.
Patterns of pulmonary structural remodelling following experimental paraquat toxicity: the morphogenesis of intraalveolar fibrosis.
Am J Pathol, 118 (1985), pp. 452-475
[12.]
C.F. Brown, P.C. Prath, et al.
Characterization of pulmonary cellular influx differentials to known toxic agents between species.
Inflammation, 6 (1982), pp. 327-341
[13.]
R.S.N. Somayajulu, S. Mukherjee, et al.
Pulmonary oxygen toxicity in chickens and rabbits.
Undersea Biomed, 5 (1978), pp. 1-7
[14.]
R.M. Du Bois.
The alveolar macrophage.
Thorax, 40 (1985), pp. 321-327
[15.]
A.O. Fels, Z.A. Cohn.
The alveolar macrophage.
J Appl Physiol, 60 (1986), pp. 353-369
[16.]
H. Mensing, B.M. Czarnetzki.
Leukotriene B4 induces in vitro fibroblast chemotaxis.
J Invest Dermat, 82 (1984), pp. 9-12
[17.]
E.J. Campbell, R.M. Senior, et al.
Extracellular matrix injury during lung inflammation.
Chest, 92 (1987), pp. 161-167
[18.]
P.B. Bitterman, S.I. Rennard, et al.
Human alveolar macrophage growth factor for fibroblasts: regulation and partial characterization.
J Clin Invest, 70 (1982), pp. 806-822
[19.]
H. Seppa, G. Grotendorst, et al.
Platelet-derived growth factor is chemotactic for fibroblasts.
J Cell Biol, 92 (1982), pp. 584-588
[20.]
E.A. Bauer, T.W. Cooper, et al.
Stimulation of in vitro human skin collagenase expression by platelet-derived growth factor.
Proc Natl Acad Sci USA, 82 (1985), pp. 4.152-4.156
[21.]
M.B. Sporn, A.B. Roberts, et al.
Transforming growth factor P:biological function and Chemical structure.
Science, 233 (1986), pp. 532-534
[22.]
A.E. Postlethwaite, Keski-Oja, et al.
Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor β.
J Exp Med, 165 (1987), pp. 251-256
[23.]
J. Varga, J. Rosenbloom, et al.
Transforming growth factor p (TGF-β) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNA's in normal human dermal fíbroblasts.
Biochem, 247 (1987), pp. 597-604
[24.]
C.J. Roberts, T.M. Birkenmeir, et al.
Transforming growth factor P stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor for cultured human lung fíbroblasts.
J Biol Chem, 236 (1988), pp. 4.585-4.592
[25.]
B.J. Sugarman, B.B. Aggarwal, et al.
Recombinant human tumor necrosis factor a Effects on proliferation of normal and transformed cells in vitro.
Science (Wash. DC), 280 (1985), pp. 943-945
[26.]
J.M. Dayer, B. Beutler, et al.
Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production for human synovial cells and dermal fíbroblasts.
J Exp Med, 162 (1985), pp. 2.163-2.168
[27.]
J.A. Elias, R.C. Krol, et al.
Regulation of human lung fibroblast glycosaminoglican production by recombinant interferon, tumor necrosis factor and lymphotoxin.
J Clin Invest, 82 (1988), pp. 325-333
[28.]
L.R. Lamontagne, J. Gauldie, et al.
In vivo initiation of unstimulated in vitro interleukin-1 release by alveolar macrophages.
Am Rev Respir Dis, 131 (1985), pp. 326-330
[29.]
M. Jordana, C. Richards, et al.
Spontaneous in vitro release of alveolar macrophage cytokines after the intratracheal administration. of bleomycin in rats: characterization and kinetic studies.
Am Rev Respir Dis, 137 (1988), pp. 1.135-1.140
[30.]
C.A. Dinarello.
An update on human interleukin-1: from molecular biology to clinical relevance.
J Clin Immunol, 5 (1985), pp. 287-296
[31.]
J. Gauldie, C. Richards, et al.
Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocytestimulating factor and regulates the major acute phase protein response in liver cells.
Proc Natl Acad Sci USA, 84 (1987), pp. 7.451-7.455
[32.]
K. Yamauchi, Y. Martinet, et al.
Modulation of fibronectin gene expression in human mononuclear phagocyts.
J Clin Invest, 80 (1987), pp. 1.720-1.727
[33.]
R.G. Crystal, P.B. Bitterman, et al.
Interstitial lung diseases of unknown cause (First of two parts).
N Eng J Med, 310 (1984), pp. 154-160
[34.]
R.H. Goldstein, A. Fine.
Fibrotic reactions in the lung: the activation of the lung fibroblast.
Exp Lung Res, 11 (1986), pp. 245-261
[35.]
C.G. Elliot, A.H. Morris, et al.
Pulmonary function and exercise gas exchange in survivors of adult respiratory distress syndrome.
Am Rev Respir Dis, 123 (1981), pp. 492-495
[36.]
P.D. Potgieter, E. Rosenthal, et al.
Immediate and long-term survival in patients admitted to a respiratory ICU.
Crit Care Med, 13 (1985), pp. 798-802
[37.]
J. Yahav, P. Lieberman, et al.
Pulmonary function following the adult respiratory distress syndrome.
Chest, 74 (1978), pp. 247-250
[38.]
H.H. Rotman, T.F. Lavelle, et al.
Long-term physiologic consequences of the adult respiratory distress syndrome.
Chest, 72 (1977), pp. 190-192
[39.]
M.W. Peterson, M. Monick, et al.
Prognostic role of eosinophils in pulmonary fibrosis.
Chest, 92 (1987), pp. 51-56
[40.]
O. Kawanami, V.J. Ferrans, et al.
Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders.
Lab Invest, 40 (1979), pp. 717-734
[41.]
T. Goto, D.A. Befus, et al.
Mast cell heterogeneity and hyperplasia in bleomycin-induced pulmonary fibrosis of rats.
Am Rev Respir Dis, 130 (1984), pp. 797-802
[42.]
M.M.F. Wagner, R.E. Edwards, et al.
Mast cells and inhalation of asbestos in rats.
Thorax, 39 (1984), pp. 539-544
[43.]
S. Watanabe, K. Watanabe, et al.
Mast cells in the rat alveolar septa undergoing fibrosis after ionising radiation.
Lab Invest, 31 (1974), pp. 555-561
[44.]
E.S. Schulman, M.C. Liu, et al.
Human lung macrophages induce histamine release from basophils and mast cells.
Am Rev Respir Dis, 131 (1985), pp. 230-235
[45.]
M. Jordana, A.D. Befus, et al.
Effect of histamine on proliferation of normal human adult lung fíbroblasts.
Thorax, 43 (1988), pp. 552-558
[46.]
F.M. Atkins, D.D. Metcalfe.
Degradation of the heparin matrix of mast cells granules by cultures fíbroblasts.
J Immunol, 131 (1983), pp. 1.420-1.425
[47.]
V. Pilarisetti, Subba Rao, et al.
Phagocytosis of mast cell granules by cultured fíbroblasts.
J Immunol, 130 (1982), pp. 341-349
[48.]
H.N. Claman.
Mast cells T cells and abnormal fibrosis.
Immunology Today, 6 (1985), pp. 192-195
[49.]
D. Metclaf.
The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors.
Blood, 67 (1986), pp. 257-267
[50.]
G.C. Bagby, McCall, et al.
A monokine regulates CSA production by vascular endothelial cells.
Blood, 62 (1983), pp. 663-668
[51.]
G.C. Babby, V.D. Rigas, et al.
Interaction of lactoferrin, monocytes and T-lymphocytes subsets in the regulation of steady-state granulopoiesis in vitro.
J Clin Invest, 68 (1981), pp. 56-63
[52.]
M. Lee, G.M. Segal, et al.
Interleukin-1 induces human bone marrow-derived fíbroblasts to produce multilineage hematopoietic growth factors.
Exp Hematol, 15 (1987), pp. 983-988
[53.]
K. Kaushansky, N. Lin, et al.
Interleukin-1 stimulates fibroblasts to synthesize granulocyte-macrophage and granulocyte colonystimulating factors.
J Clin Invest, 81 (1988), pp. 92-97
[54.]
J.R. Zucali, H.E. Broxmeyer, et al.
Recombinant human tumor necrosis factors α and β stimulate fibroblasts to produce hemopoietic growth factors in vitro.
J Immunol, 140 (1988), pp. 840-844
[55.]
L. Kobzik, R. Rose.
Alveolar macrophage response to recombinant colony-stimulating factors.
Am Rev Respir Dis, 137 (1988), pp. A38
[56.]
C. Vancheri, T. Ohtoshi, et al.
Human lung fibroblast-derived GM-CSF induces survival of peripheral blood eosinophils in vitro.
Am J Resp Cell and Mol Biol, 1 (1989), pp. 289-295
[57.]
R.A. Bradshaw, M. Young.
Nerve growth factor Recent developments and perspectives.
Biochem Pharmacol, 25 (1976), pp. 1.445-1.448
[58.]
pp. 1-56
[59.]
A.K.C. Li, M.J. Koroly, et al.
Nerve growth factor: acceleration of the rate of wound healing in mice.
Proc Natl Acad Sci USA, 77 (1980), pp. 4.379-4.381
[60.]
A. Bruni, E. Bigan, et al.
Interaction between nerve growth factor and lysophosphatidyilserine on rat peritoneal mast cells.
FEBS Letters, 138 (1982), pp. 190-192
[61.]
F.L. Pearce, H.L. Thompson.
Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor.
J Physiol, 372 (1986), pp. 379-393
[62.]
F. Shanahan, J. Denburg, et al.
Mast cell heterogeneity effect of neuroenteric peptides on histamine release.
J Immunol, 135 (1985), pp. 1.331-1.337
[63.]
M. Lotz, J.H. Vaughan, et al.
Effect of neuropeptides on production of inflammatory cytokines by human monocytes.
Science, 241 (1988), pp. 1.218-1.221
[64.]
J. Gauldie, M. Jordana, et al.
The release of interferon β2/BSF-2/HSF/1L-6 by the human lung fibroblast mediates the acute-phase response during lung inflammation.
Am Rev Respir Dis, 137 (1988), pp. A49
[65.]
C.P. Chiu, F. Lee.
IL-6 is a differentiation factor for MI and WEHI-3B myeloid leukemic cells.
J Immunol, 142 (1989), pp. 1.909-1.915
[66.]
C. Miyaura, C.H. Jin, et al.
Production of interleukin-6 and its relation to the macrophage differentiation of mouse myeloid leukemia cells (MI) treated with differentiation-inducing factor and lα,25-dihidroxyvitamin D3.
Biochem and Biphys Res Com, 158 (1989), pp. 660-666
[67.]
M. Jordana, J. Schulman, et al.
Heterogeneous proliferative characteristics of human adult lung fibroblast fines and clonally derived fibroblasts from control and fibrotic tissue.
Am Rev Respir Dis, 137 (1988), pp. 579-584
[68.]
L. Irving, M. Jordana, et al.
Differences in in vitro behaviour between neonatal and adult human primary and cloned lung fibroblast fines.
Am Rev Respir Dis, 135 (1987), pp. A66
[69.]
M. Jordana, J. Schulman, et al.
Spontaneous in vitro release of growth factors by human lung fibroblasts.
Am Rev Respir Dis, 137 (1988), pp. A49
[70.]
D.R. Clemmons, L.E. Underwood, et al.
Hormonal control of immunoreactive somatomedin production by cultured human fibroblasts.
J Clin Invest, 67 (1981), pp. 10-19
[71.]
D.R. Clemmons, J.J. Van Wick.
Evidence for a functional role of endogenously produced somatomedin-like peptides in the regulation of DNA synthesis in cultured human fibroblast and porcine smooth muscle cells.
J Clin Invest, 75 (1985), pp. 1.914-1.918
[72.]
R.A. Seifert, S.M. Schwartz, et al.
Developmentally regulated production of platelet-derived growth factor-like molecules.
Nature, 311 (1984), pp. 669-671
[73.]
M.W. Majesty, E.P. Benditt, et al.
Expression and developmental control of platelet-derived growth factor A-chain and B-chain/sis genes in rat aortic smooth muscle cells.
Proc Natl Acad Sci USA, 85 (1988), pp. 1.524-1.528
[74.]
P. Libby, S.J.C. Warner, et al.
Production of platelet-derived growth factor-like mitogen by smooth muscle cells from human atheroma.
N Eng J Med, 318 (1988), pp. 1.493-1.498
[75.]
C. McSharry, M. Jordana, et al.
Procollagen gene expression by primary fibroblast fines derived from control and fibrotic lung tissue in humans.
Am Rev Respir Dis, 135 (1987), pp. A306
[76.]
E.C. Leroy.
Increased collagen synthesis by scleroderma skin. fibroblasts in vitro. A possible deffect in the regulation or activation of the scleroderma fibroblasts.
J Clin Invest, 54 (1974), pp. 880-889
[77.]
P.N. Graves, I.K. Weiss, et al.
Increased procollagen mRNA levels in scleroderma skin fibroblasts.
J Invest Dermatol, 80 (1983), pp. 130-132
[78.]
K. Scharffetter, B. Lankat-Buttgereit, et al.
Localization of collagen mRNA in normal and scleroderma skin by in situ hybridization.
Eur J Clin Invest, 18 (1988), pp. 9-17
[79.]
K. Veli-Matti, M. Sandberg, et al.
Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hibridization.
J Invest Dermatol, 90 (1988), pp. 664-670
[80.]
G.J. Laurent.
Lung collag more than scaffolding.
Thorax, 41 (1986), pp. 418-428
[81.]
M. Selman, M. Montano, et al.
Concentration, biosynthesis and degradation of collagen in idiopathic pulmonary fibrosis.
Thorax, 41 (1986), pp. 355-359
[82.]
R. Pérez-Tamayo, I. Montfort, et al.
Collagenolytic activity in experimental cirrhosis of the liver.
Exp Mol Pathol, 47 (1987), pp. 300-308
[83.]
R.B. Low, J. Woodcock-Mitchell, et al.
Actin content of normal and of bleomycin-fibrotic rat.
Am Rev Respir Dis, 129 (1984), pp. 311-316
[84.]
K.B. Adler, J.E. Craighead, et al.
Actin-containing cells in human pulmonary fibrosis.
Am J Pathol, 102 (1981), pp. 427-437
[85.]
Y. Kapanci, A. Assimacopoulus, et al.
Contractile interstitial cells in pulmonary alveolar septa: a possible regulator of ventilation/perfusion ratio?.: ultrastructural, immunofluorescence and in vitro studies.
J Cell Biol, 60 (1974), pp. 375-392
[86.]
R.H. Golstein, E.C. Lucy, et al.
Failure of mechanical properties in bleomycin-induced pulmonary fibrosis.
Am Rev Respir Dis, 120 (1979), pp. 67-73
[87.]
G.R. Botstein, G.K. Sherer, et al.
Fibroblast selection in scleroderma: an alternative model of fibrosis.
Arthritis Rheum, 25 (1982), pp. 189-195
[88.]
M.B. Sporn, A.B. Roberts.
Peptide growth factors and inflammation, tissue repair and cancer.
J Clin Invest, 78 (1986), pp. 329-332
[89.]
R.B. Dreising, M.L. Schawartz, et al.
Circulating immunocomplexes in the idiopathic interstitial pneumonias.
N Eng J Med, 298 (1978), pp. 353-357
[90.]
G.W. Hunninghake, J.E. Gadek, et al.
Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis.
J Clin Invest, 68 (1981), pp. 259-269
[91.]
L. Reid, D. Jefferson.
Cell cultures using extracts of extracellular matrix to study growth and differentiation in mammalian cells.
Mammalian Cell Culture., pp. 239-280
[92.]
Extracellular matrix influence on gene expression.,
[93.]
M.Y. Gordon, G.P. Riley, et al.
Compartmentalization of a hemopoietic growth factor (GM-CSF) by glycosaminoglicans in the bone marrow microenvironment.
Nature, 326 (1987), pp. 403-405
[94.]
D.H. Bowden.
Cell turnover in the lung.
Am Rev Respir Dis, 128 (1983), pp. 545-548
[95.]
R.K. Assoian, G.R. Grotendorst, et al.
Cellular transformation by coordinated action of three peptide growth factors from human platelets.
Nature, 309 (1984), pp. 804-806
[96.]
E.B. Leof, J.A. Proper, et al.
Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor β: A proposed model for indirect mitogenesis involving autocrine activity.
Proc Natl Acad Sci USA, 83 (1986), pp. 2.453-2.457
[97.]
Shoshan, Shmuel.
Wound healing.
International Rev Conn Tissue Res, 9 (1981), pp. 1-27
Copyright © 1989. Sociedad Española de Neumología y Cirugía Torácica
Idiomas
Archivos de Bronconeumología

Suscríbase a la newsletter

Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?